Determinants of Myelosuppression in the Treatment of Non‐small Cell Lung Cancer with Cisplatin‐containing Chemotherapy

Data on 16 potential risk factors for myelosuppression were assessed in 134 patients who received either vindesine and cisplatin (VP) or mitomycin C, vindesine and cisplatin (MVP) for inoperable stage III or IV non‐small cell lung cancer in a randomized trial. Determinant factors for myelosuppressio...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Jpn J Cancer Res
Asıl Yazarlar: Matsui, Kaoru, Masuda, Noriyuki, Uchida, Yasuo, Fukuoka, Masahiro, Negoro, Shunichi, Yana, Takashi, Kusunoki, Yoko, Kudoh, Shinzoh, Kawase, Ichiro, Kawahara, Masaaki, Ogawara, Mitsumasa, Kodama, Nagahisa, Kubota, Kaoru, Furuse, Kiyoyuki
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Blackwell Publishing Ltd 1996
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC5921149/
https://ncbi.nlm.nih.gov/pubmed/8698630
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1349-7006.1996.tb00292.x
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller